SE0202608D0 - New sequences - Google Patents
New sequencesInfo
- Publication number
- SE0202608D0 SE0202608D0 SE0202608A SE0202608A SE0202608D0 SE 0202608 D0 SE0202608 D0 SE 0202608D0 SE 0202608 A SE0202608 A SE 0202608A SE 0202608 A SE0202608 A SE 0202608A SE 0202608 D0 SE0202608 D0 SE 0202608D0
- Authority
- SE
- Sweden
- Prior art keywords
- new sequences
- agents
- useful
- ceta
- pkc
- Prior art date
Links
Abstract
The invention relates to the use of the human Protein Kinase Ceta (PKC-eta) isoform, in methods for identification of pharmaceutically useful agents, in particular agents useful for the treatment of type 2 diabetes.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202608A SE0202608D0 (en) | 2002-09-04 | 2002-09-04 | New sequences |
AU2003256209A AU2003256209A1 (en) | 2002-09-04 | 2003-09-03 | Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
PCT/SE2003/001361 WO2004022592A1 (en) | 2002-09-04 | 2003-09-03 | Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202608A SE0202608D0 (en) | 2002-09-04 | 2002-09-04 | New sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0202608D0 true SE0202608D0 (en) | 2002-09-04 |
Family
ID=20288884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0202608A SE0202608D0 (en) | 2002-09-04 | 2002-09-04 | New sequences |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003256209A1 (en) |
SE (1) | SE0202608D0 (en) |
WO (1) | WO2004022592A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007089546A (en) * | 2005-09-30 | 2007-04-12 | Univ Of Tokushima | Rheumatoid arthritis susceptible gene and method for measuring risk of rheumatoid arthritis |
WO2007123233A1 (en) | 2006-04-25 | 2007-11-01 | Kyushu University, National University Corporation | Gene associated with arteriosclerotic disease, and use thereof |
WO2018150430A1 (en) * | 2017-02-19 | 2018-08-23 | The National Institute for Biotechnology in the Negev Ltd. | Peptide kinase inhibitors and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1490509A4 (en) * | 2001-01-12 | 2005-06-01 | Exelixis Inc | Modulating insulin receptor signaling |
-
2002
- 2002-09-04 SE SE0202608A patent/SE0202608D0/en unknown
-
2003
- 2003-09-03 WO PCT/SE2003/001361 patent/WO2004022592A1/en not_active Application Discontinuation
- 2003-09-03 AU AU2003256209A patent/AU2003256209A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004022592A1 (en) | 2004-03-18 |
AU2003256209A1 (en) | 2004-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60327999D1 (en) | AZOLYLAMINOAZINES AS INHIBITORS OF PROTEIN KINASES | |
ATE451376T1 (en) | COMPOSITIONS SUITABLE AS INHIBITORS OF PROTEIN KINASES | |
DE60314603D1 (en) | COMPOSITIONS NECESSARY AS PROTEIN KINASE INHIBITORS | |
ATE466580T1 (en) | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS | |
ATE468336T1 (en) | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS | |
DE602004014117D1 (en) | THIAZOLE FOR USE AS INHIBITORS OF PROTEIN KINASES | |
UA85559C2 (en) | Aminobenzophenone compounds | |
BR0116452A (en) | Compound, pharmaceutical composition, use of a compound | |
DE602004021585D1 (en) | 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE FOR USE IN THE TREATMENT OF BLOOD HIGH PRESSURE | |
DE60314500D1 (en) | DIAMINOPYRIMIDINE AND ITS USE AS ANGIOGENESEHEMMER | |
SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
DK1368060T3 (en) | HMGB1 protein inhibitors and / or antagonists for the treatment of vascular disease | |
YU9404A (en) | Peptide-based multimeric targeted contrast agents | |
ATE450530T1 (en) | COMPOSITIONS FOR USE AS PROTEIN KINASE INHIBITORS | |
MXPA05013977A (en) | Methods and compositions for treating amyloid-related diseases. | |
BR0309665A (en) | Treatment of alpha-galactosidase deficiency at | |
HK1062923A1 (en) | Igf-binding protein-derived peptide | |
NO20055741L (en) | New chemical compounds | |
DE602004012578D1 (en) | PYROME COMPOSITIONS SUITED AS INHIBITORS OF C-MET | |
WO2003104425A3 (en) | Novel stable anti-cd22 antibodies | |
CY1110130T1 (en) | MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A. | |
RS51138B (en) | S-mirtazapine for the treatment of hot flush | |
SE0302304D0 (en) | Novel compounds | |
ATE522230T1 (en) | BIPHENYLE AS AN IMAGING AGENT IN ALZHEIMER'S DISEASE | |
NO20060781L (en) | Use of soluble CD164 in inflammatory and / or autoimmune disorders |